Menu
Back to Journals » OncoTargets and Therapy » Volume 14
The Inhibitive Effect of sh-HIF1A-AS2 on the Proliferation, Invasion, and Pathological Damage of Breast Cancer via Targeting miR-548c-3p Through Regulating HIF-1α/VEGF Pathway in vitro and vivo [Retraction]
Received 4 February 2021
Accepted for publication 4 February 2021
Published 11 February 2021 Volume 2021:14 Pages 1003—1004
Guo X, Lee S, Cao P. Onco Targets Ther. 2019;12:825—834.
The Editor and Publisher of OncoTargets and Therapy wish to retract the published article.
The journal was notified of potential image duplication between Figures 4A and 5D:
This retraction relates to this paper
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.